Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Abstract The emergence of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) with activating EGFR mutations is a major hindrance to treatment. We investigated the effects of p53 in primary sensitivity and acquired resistance...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4f71769b43da4ae2a10dadce8fbefd82 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|